Michael Berry
Chief Tech/Sci/R&D Officer chez EVEREST MEDICINES LIMITED
Postes actifs de Michael Berry
Sociétés | Poste | Début | Fin |
---|---|---|---|
EVEREST MEDICINES LIMITED | Chief Tech/Sci/R&D Officer | 15/06/2023 | - |
Historique de carrière de Michael Berry
Anciens postes connus de Michael Berry
Sociétés | Poste | Début | Fin |
---|---|---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01/02/2015 | 01/08/2017 |
PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2013 | 01/02/2015 |
Novartis Vaccines & Diagnostics SL | Corporate Officer/Principal | 01/04/2010 | 01/09/2013 |
ARCA BIOPHARMA, INC. | Director/Board Member | 01/04/2005 | 01/05/2009 |
CLOVER BIOPHARMACEUTICALS, LTD. | Chief Tech/Sci/R&D Officer | 15/03/2021 | - |
Formation de Michael Berry
The University of Manchester | Graduate Degree |
University of Manitoba | Doctorate Degree |
De Montfort University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Israël | 2 |
Canada | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
ARCA BIOPHARMA, INC. | Health Technology |
EVEREST MEDICINES LIMITED | Health Technology |
CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Novartis Vaccines & Diagnostics SL |
- Bourse
- Insiders
- Michael Berry
- Expérience